In the latest trading session, 24.95 million Eterna Therapeutics Inc (NASDAQ:ERNA) shares changed hands as the company’s beta touched 4.28. With the company’s most recent per share price at $0.34 changed hands at -$0.02 or -4.36% at last look, the market valuation stands at $17.68M. ERNA’s current price is a discount, trading about -670.59% off its 52-week high of $2.62. The share price had its 52-week low at $0.36, which suggests the last value was -5.88% down since then. When we look at Eterna Therapeutics Inc’s average trading volume, we note the 10-day average is 0.32 million shares, with the 3-month average coming to 107.39K.
Eterna Therapeutics Inc (NASDAQ:ERNA) trade information
Instantly ERNA was in red as seen in intraday trades today. With action -26.45%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -80.82%, with the 5-day performance at -26.45% in the red. However, in the 30-day time frame, Eterna Therapeutics Inc (NASDAQ:ERNA) is -67.82% down. Looking at the short shares, we see there were 44458.0 shares sold at short interest cover period of 1.07 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 336.35% of Eterna Therapeutics Inc shares while 11.00% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at -4.65%.
Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 26.1 shares estimated at $8161.0 under it, the former controlled 0.05% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.03% of the shares, roughly 13.34 shares worth around $4172.0.
